Mody, R., Yu, A. L., Naranjo, A., Zhang, F. F., London, W. B., Shulkin, B. L., . . . Bagatell, R. (2020). Irinotecan, Temozolomide, and Dinutuximab With GM-CSF in Children With Refractory or Relapsed Neuroblastoma: A Report From the Children’s Oncology Group. J Clin Oncol.
Citação norma ChicagoMody, Rajen, et al. "Irinotecan, Temozolomide, and Dinutuximab With GM-CSF in Children With Refractory or Relapsed Neuroblastoma: A Report From the Children’s Oncology Group." J Clin Oncol 2020.
Citação norma MLAMody, Rajen, et al. "Irinotecan, Temozolomide, and Dinutuximab With GM-CSF in Children With Refractory or Relapsed Neuroblastoma: A Report From the Children’s Oncology Group." J Clin Oncol 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.